About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- 216 adults with obesity and at-risk MASLD, recruited in the United States and Spain
- Sample size
- 216
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Correction status
- Author correction published: Nature Medicine 2026 (DOI 10.1038/s41591-026-04650-w, PMID 42642663). Content of the correction not read.
- Date checked
- 14 November 2026
Limitations
Short (48 weeks), two countries only, liver fat measured by imaging rather than biopsy outcomes. Funding statement not shown in the Europe PMC record; several authors are Boehringer Ingelheim staff. An author correction has been published (PMID 42642663); its content was not read.
Cited in
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.